Closed · HR001119S0092 · CFDA 12.910 · Discretionary
Focused Pharma
Federal grant opportunity posted by DARPA - Biological Technologies Office, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- November 19, 2019
- Close date
- -
- Expected awards
The verdict
Focused Pharma is a closed discretionary listing from DARPA - Biological Technologies Office that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 73 other opportunities from DARPA - Biological Technologies Office.
- Varies
- award range
- Closed
- application status
- 12.910
- CFDA program
- 73
- other opportunities from DARPA - Biological Technologies Office
Archived opportunity record
Focused Pharma is closed (last close November 19, 2019). Check the agency catalog for replacement NOFOs. DARPA - Biological Technologies Office still indexes 73 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed November 19, 2019
Instrument
Procurement Contract
Description
Military service members and veterans face serious occupational trauma; one element in particular relates to the significantly increased risk of acute and chronic neuropsychiatric conditions. Neuropsychiatric conditions in the military are particularly impactful because options for treating them are limited. No therapy currently exists that can deliver rapid relief of neuropsychiatric symptoms and is reasonable for use in a broad spectrum of conditions. Neuropsychiatric conditions are complex, and presentation is highly subject to significant inter-individual variability. Focused Pharma aims to develop new drugs that target specific neurotransmitter receptor signaling modes to deliver near immediate relief that is generalizable across indications and individuals.
Catch-all / unrestricted eligibility mark · HR001119S0092
Grants.gov marks Focused Pharma with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Procurement Contract. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the DARPA - Biological Technologies Office book (44 peers, 59% of 74).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
BAA Coordinator FocusedPharma@darpa.mil
More from DARPA - Biological Technologies Office
What to do next
Focused Pharma is closed; use the parent program and agency catalog for the next funding cycle.
- Browse open federal opportunities in the same category when this listing is closed. Open opportunities
- Look up CFDA 12.910 across all indexed listings before you commit to this opportunity alone. Eligibility finder
- Compare award ranges across federal categories before you pick a single CFDA. All categories
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |